Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0 GBP
−7.67 M GBP
506.00 K GBP
5.23 M
About 4BASEBIO PLC ORD EUR1
Sector
Industry
CEO
Heikki Lanckriet
Website
Headquarters
Cambridge
Founded
2020
ISIN
GB00BMCLYF79
FIGI
BBG00Z46T823
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4BB is 1,210 GBX — it has decreased by −0.76% in the past 24 hours. Watch 4BASEBIO PLC ORD EUR1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange 4BASEBIO PLC ORD EUR1 stocks are traded under the ticker 4BB.
4BB stock has fallen by −0.76% compared to the previous week, the month change is a −6.67% fall, over the last year 4BASEBIO PLC ORD EUR1 has showed a 77.94% increase.
We've gathered analysts' opinions on 4BASEBIO PLC ORD EUR1 future price: according to them, 4BB price has a max estimate of 1,800.00 GBX and a min estimate of 1,800.00 GBX. Watch 4BB chart and read a more detailed 4BASEBIO PLC ORD EUR1 stock forecast: see what analysts think of 4BASEBIO PLC ORD EUR1 and suggest that you do with its stocks.
4BB stock is 2.89% volatile and has beta coefficient of 0.20. Track 4BASEBIO PLC ORD EUR1 stock price on the chart and check out the list of the most volatile stocks — is 4BASEBIO PLC ORD EUR1 there?
Today 4BASEBIO PLC ORD EUR1 has the market capitalization of 183.34 M, it has decreased by −2.07% over the last week.
Yes, you can track 4BASEBIO PLC ORD EUR1 financials in yearly and quarterly reports right on TradingView.
4BASEBIO PLC ORD EUR1 is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
4BB net income for the last half-year is −5.73 M GBP, while the previous report showed −4.11 M GBP of net income which accounts for −39.37% change. Track more 4BASEBIO PLC ORD EUR1 financial stats to get the full picture.
No, 4BB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 84.00 employees. See our rating of the largest employees — is 4BASEBIO PLC ORD EUR1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4BASEBIO PLC ORD EUR1 EBITDA is −7.53 M GBP, and current EBITDA margin is −1.25 K%. See more stats in 4BASEBIO PLC ORD EUR1 financial statements.
Like other stocks, 4BB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4BASEBIO PLC ORD EUR1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4BASEBIO PLC ORD EUR1 technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4BASEBIO PLC ORD EUR1 stock shows the buy signal. See more of 4BASEBIO PLC ORD EUR1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.